Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

388.14 -1.57 (-0.40%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
NextDecade, GigaCloud Technology And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 
Via MarketBeat
Exposures COVID-19 Product Safety
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,900 Today
Via Benzinga
Analyst Ratings for Stryker
Via Benzinga
$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
Via Benzinga
RBC Capital Maintains Outperform Rating for Stryker: Here's What You Need To Know
Via Benzinga
What's Going On With Stryker Stock Today
The orthopedic and surgical device giant Stryker Corporation (NYSE: SYK) stock is trading lower despite reporting Q1 earnings beat and an upbeat outlook. 
Via Benzinga
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
From Stryker
Via Business Wire
Microbot Medical spikes 150% on its Endovascular Surgical Robot
Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERT 
Via MarketBeat
Exposures Product Safety
Meta Platforms, JPMorgan And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Which Is the Safer Dividend Stock: Stryker or Medtronic?
Both are on the safer side, but one is increasing its dividend payout a bit faster. 
Via The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
Earnings Preview For Stryker
Via Benzinga
2 Top Stocks to Buy in April and Hold Forever
The need for healthcare goods and/or services is here to stay. 
Via The Motley Fool
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
These two companies are leaders in their industries, and they're relatively safe, too. 
Via The Motley Fool
Strong Sales and Momentum Propel Stryker to Stellar Q1 Results: Analysts Keep a Watchful Eye on Future Profitability
Stryker Corporation (NYSE: SYK) reported Q1 sales of $4.80 billion, up 11.8% Y/Y (+14% in constant currency), beating the  
Via Benzinga
Stryker Gets Price Target Hikes By Analysts Following Upbeat Q1 Results
Stryker Corporation (NYSE: SYK) reported better-than-expected earnings for its first quarter and increased its full-year profit outlook. 
Via Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
MGM Resorts To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Tuesday
Credit Suisse boosted the price target for KBR, Inc. (NYSE: KBR) from $68 to $71. Credit Suisse analyst Jamie Cook maintained an Outperform rating. KBR shares rose 4.4% to close at $59.16 on Monday. 
Via Benzinga
Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stryker reports first quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
All three of these companies have seen double-digit increases in their share prices this year. 
Via The Motley Fool
Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
These 3 Stocks Might Be Getting a Little Too Expensive
These are promising businesses, but you might want to hold off on buying shares -- for now. 
Via The Motley Fool
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
Microsoft To Rally Around 9%? Here Are 10 Other Analyst Forecasts For Monday
RBC Capital raised the price target for Pinterest, Inc. (NYSE: PINS) from $26 to $30. RBC Capital analyst Brad Erickson maintained a Sector Perform rating. Pinterest shares gained 1.5% to $27.68 in... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.